Pulmonary Hypertension Due to Left Heart Disease Clinical Trials

7 clinical trials for Pulmonary Hypertension Due to Left Heart Disease across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension. — RECRUITING
• Pulmonary Hypertension Biorepository and Registry — RECRUITING
• Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension — RECRUITING · PHASE4
• A Study to Learn How Safe the Study Treatment BAY2701250 is, How it Affects the Body and How it Moves Into, Through and Out of the Body in Healthy Male Participants When a Single Amount is Given as an Injection Into the Vein (Intravenous Infusion) or Under the Skin (Subcutaneous Injection) — COMPLETED · PHASE1
• Telemonitoring to Treat Group 2 Pulmonary Hypertension — WITHDRAWN · PHASE2
• Training in HFpEF-PH — NOT_YET_RECRUITING · NA
• Registry for Pulmonary Hypertension Due to Left Heart Disease in China — OTHER

Refine this search